Abstract
Maternal IGFs regulate cytotrophoblast proliferation and, thereby, placental growth and function.IGF bioavailability is controlled by IGF-binding proteins (IGFBPs); in placenta, IGFBP-3 is particularly abundant. In other systems, IGFBP-3 can regulate cellular events independently of IGFs; these effects are thought to be mediated by TGFβreceptors (TβR).We have examined IGFBP-3 regulation of IGF-dependent and -independent cytotrophoblast proliferation in first-trimester placental explants and the role of TβRII in mediating these effects. In the presence of IGFBP-3 (50 nM), IGF-induced (10 nM) proliferation (monitored by immunohistochemical analysis of Ki67 expression and bromodeoxyuridine incorporation) was significantly reduced (P
Original language | English |
---|---|
Pages (from-to) | 1723-1731 |
Number of pages | 8 |
Journal | Endocrinology |
Volume | 151 |
Issue number | 4 |
DOIs | |
Publication status | Published - Apr 2010 |